About
Approach
Investment Model
Investment Scope
Our approach
Team
Managing Partner
Partners
Our team
Portfolio
News
Connect
Pages
Pages
Home
About
Blog
Blog Post
Contact
Portfolio
Investors
Investor Single
Shop
Shop Single
Utility Pages
Start Here
Style Guide
404 Not Found
Password Protected
Licenses
Changelog
Browse More Templates
News
Recent news about Panacea Capital and select portfolio companies
April 3, 2026
Winning in Biosimilars: Speed, Scale, and the New Competitive Playbook
April 3, 2026
Winning in Biosimilars: Speed, Scale, and the New Competitive Playbook
March 27, 2026
Chime Biologics Congratulates Hope Medicine Inc. on Successful Dosing of First Patient in Phase III Clinical Trial for Endometriosis in China
March 27, 2026
Chime Biologics Congratulates Hope Medicine Inc. on Successful Dosing of First Patient in Phase III Clinical Trial for Endometriosis in China
March 26, 2026
pharmaphorum – BIO‑Europe Spring 2026: In conversation with Marjorie Sidhoum, Vice President of Business Development and Corporate Communications at Kainova Therapeutics
March 26, 2026
pharmaphorum – BIO‑Europe Spring 2026: In conversation with Marjorie Sidhoum, Vice President of Business Development and Corporate Communications at Kainova Therapeutics
March 26, 2026
Kainova Therapeutics to Present Clinical and Preclinical Updates on its GPCR Programs at AACR Annual Meeting 2026
March 26, 2026
Kainova Therapeutics to Present Clinical and Preclinical Updates on its GPCR Programs at AACR Annual Meeting 2026
March 25, 2026
The Rare Disease Conversation Is Getting Louder. Here’s Where Myrtelle Stands.
March 25, 2026
The Rare Disease Conversation Is Getting Louder. Here’s Where Myrtelle Stands.
1 / 10
Next